Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants

N Engl J Med. 2022 Aug 4;387(5):468-470. doi: 10.1056/NEJMc2207519. Epub 2022 Jul 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal* / therapeutic use
  • Antibodies, Neutralizing* / therapeutic use
  • Antibodies, Viral / immunology
  • Antiviral Agents* / therapeutic use
  • COVID-19 Drug Treatment*
  • COVID-19* / immunology
  • Humans
  • Immunologic Factors* / therapeutic use
  • SARS-CoV-2* / drug effects
  • Vaccine Efficacy

Substances

  • Antibodies, Monoclonal
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Antiviral Agents
  • Immunologic Factors

Supplementary concepts

  • SARS-CoV-2 variants